Russian scientists unveil mRNA cancer vaccine ready for clinical use
- 08-Sep-2025
MOSCOW: Russian scientists have announced that a new mRNA-based cancer vaccine, developed by the Russian Federal Medical and Biological Agency (FMBA), is now ready for clinical use, the Sputnik News reported. According to FMBA head Veronika Skvortsova, the Enteromix vaccine has successfully completed preclinical trials, demonstrating both high efficacy and safety. “The vaccine has shown […]
Russia claims to develop own cancer vaccine
- 18-Dec-2024
Russia’s Ministry of Health has announced the development of a cancer vaccine that will be provided to patients at no cost. As reported by the state media, Andrey Kaprin, the director of the Radiology Medical Research Center within the Ministry, indicated that the vaccine is set to be introduced in early 2025. This vaccine is […]
Cancer vaccines poised to unlock ‘new treatment paradigm’
- 08-Jun-2023
Adding an experimental mRNA-based vaccine from Moderna and Merck & Co reduced the risk that the most deadly skin cancer would spread by 65% over treatment with an immunotherapy alone in a mid-stage trial, the companies reported on Monday. With this and earlier data, Moderna is considering seeking faster approval from regulators for the treatment, […]
A cancer vaccine is on the cards!
- 12-Oct-2022
Moderna and Merck will jointly develop and sell a cancer vaccine that is personalized for individual patients, the companies announced on Wednesday. Moderna’s experimental vaccine is being tested in combination with Merck’s blockbuster cancer immunotherapy, Keytruda, in a mid-stage trial to treat patients with melanoma, the deadliest form skin cancer. Data on the vaccine, mRNA-4157, […]